Optimizing the Adipogenic Induction Protocol Using Rosiglitazone Improves the Physiological Parameters and Differentiation Capacity of Adipose Tissue-Derived Mesenchymal Stem Cells for Horses, Sheep, Dogs, Murines, and Humans
Open Access
Abstract
The investigation of adipose tissue-derived mesenchymal stem cells (ASCs) has received considerable interest in regenerative medicine. A nontoxic adipogenic induction protocol valid for cells of different mammalian species has not been described. This study aims to establish an adipogenic differentiation protocol suitable for horses, sheep, dogs, murines, and human cells. An optimized rosiglitazone protocol, consisting of 5% fetal calf serum in Dulbecco’s Modified Eagle’s Medium, 10 μg/mL insulin, 0.55 μg/mL transferrin, 6.8 ng sodium selenite, 1 μM dexamethasone, and 1–5 μM of rosiglitazone, is compared to the 3-isobutyl-1-methylxantine (IBMX) protocol, where rosiglitazone was replaced with 0.5 mM IBMX and 0.2 mM indomethacin. Cell viability, cytotoxicity, a morphometric analysis of the lipid, and the expression of adipogenic markers for 14 days were assessed. The data revealed that using 5 µM of rosiglitazone promotes the adipogenic differentiation capacity in horse, sheep, and dog cells compared to IBMX induction. Meanwhile, marked reductions in the cell viability and cell number with the IBMX protocol were detected, and rosiglitazone increased the cell number and lipid droplet size, prevented apoptosis, and upregulated FABP-4 and Leptin expression in the cells of most of the species. Our data revealed that the rosiglitazone protocol improves the adipogenesis of ASCs, together with having less toxicity, and should be considered for cell reproducibility and clinical applications targeting obesity.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (AR333/11-1)
This publication has 57 references indexed in Scilit:
- Adipogenesis: From Stem Cell to AdipocyteAnnual Review of Biochemistry, 2012
- Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSCCell Communication and Signaling, 2011
- Current Methods of Adipogenic Differentiation of Mesenchymal Stem CellsStem Cells and Development, 2011
- Indomethacin promotes adipogenesis of mesenchymal stem cells through a cyclooxygenase independent mechanismJournal of Cellular Biochemistry, 2010
- PPARγ and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scaleGenes & Development, 2008
- Mesodermal fate decisions of a stem cell: the Wnt switchCellular and Molecular Life Sciences, 2008
- Mechanism by which a novel non‐thiazolidinedione peroxisome proliferator‐activated receptor γ agonist, FK614, ameliorates insulin resistance in Zucker fatty ratsDiabetes, Obesity and Metabolism, 2006
- Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose TissueStem Cells, 2006
- ADIPOCYTE DIFFERENTIATION AND LEPTIN EXPRESSIONAnnual Review of Cell and Developmental Biology, 1997
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990